Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Edward Gelmann
Professor, Medicine | Member of the Graduate Faculty
Medicine
Overview
Research
More
Collaboration
(15)
George Watts
Mutual work: 1 Grant﹒2 Proposals
Collaboration Details
Anne Cress
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Jennifer Hatcher
Mutual work: 3 Grants﹒4 Proposals
Collaboration Details
Denise Roe
Mutual work: 3 Grants﹒8 Proposals
Collaboration Details
Roberta Brinton
Mutual work: 1 Publication
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(14)
A Phase 1, Open-Label, Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects with Advanced Solid Tumors and Subsequent Expansio
Active
·
2023
·
$0 / $735.4K
·
External
Co-Investigator (COI)
cancer,
pharmacokinetics,
clinical effects,
intravenous administration,
safety
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Canc
Active
·
2023
·
$0 / $454.6K
·
External
Co-Investigator (COI)
prostate cancer,
cancer treatment,
clinical trial,
metastatic cancer,
drug combination
The Robert A.Winn Diversity in Clinical Trials: Career Development Award
Active
·
2023
·
$0 / $240K
·
External
Key Personnel (KP)
clinical trials,
diversity,
career development,
research,
healthcare disparities
DYRK1B Inhibition for Prostate Cancer
Active
·
2023
·
$145.8K / $153.5K
·
External
Principal Investigator (PI)
prostate cancer,
dyrk1b inhibition,
cancer treatment,
molecular targeting,
drug development
University of Arizona Cancer Center - Cancer Center Support Grant
Active
·
2022
·
$0 / $8.7M
·
External
Key Personnel (KP)
cancer research,
medical oncology,
grants,
cancer treatment,
supportive care
Page 1 of 3
Previous page
Next page
Publications
(18)
Recent
Data from CRISPR/Cas9-Mediated Point Mutation in i>Nkx3.1<i> Prolongs Protein Half-Life and Reverses Effects i>Nkx3.1<i> Allelic Loss
2023
crispr/cas9,
gene editing,
protein stability,
mutation,
gene expression
Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
2022
prostate cancer,
androgen-targeting,
gnrh agonist,
neurodegenerative disease,
therapeutics
CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss
2020
genome editing,
protein stability,
gene expression,
cancer research,
molecular biology
CRISPR/Cas9-Mediated Point Mutation in Prolongs Protein Half-Life and Reverses Effects Allelic Loss
2020
Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression
2019
cancer,
genetics,
prostate,
tumor suppressor,
cell signaling
Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression
2018
prostate cancer,
tissue microarray,
annexin a7,
prognostic role,
cancer progression
Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate
2018
cancer research,
medical network,
prostate cancer,
epidemiology,
public health
Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors
2016
prostate cancer,
metastases,
solid tumors,
treatment,
lessons
Nkx3.1 controls the DNA repair response in the mouse prostate
2016
dna repair,
prostate cancer,
gene regulation,
mouse model,
cellular response
The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase
2015
cancer,
cell biology,
protein degradation,
kinase signaling,
tumor suppressor